Cyclacel Pharmaceuticals (CYCC) Stock Highlights

1.05 | +2.94%

2024-09-19 07:13:46

Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company which develops targeted medicines for cancer and other proliferative diseases. It develops several families of anticancer drugs that act on the cell cycle, including nucleoside analogs, CDK (cyclin dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include CYC065 CDK inhibitor, Sapacitabine and seliciclib, CYC682, CYC140 PLK inhibitor, and CYC202. It earns the majority of its revenue from the United Kingdom.

Statistics

Range Today

1 1.07

Volume Today 33.5K

Range 1 Year

0.95 11.4

Volume 1 Year 70.71M

Range 3 Year

0.95 91.5

Volume 3 Year 78.75M

Range 10 Year

0.95 13392

Volume 10 Year 90.31M

Highlights

Market Capitalization 1.99M (micro)

Floating Shares 1.76M

Current Price 1.05

Price To Earnings -0.07

Price To Revenue -50.01

Price To Book 1.83

Earnings Per Share -15.31

Payout Ratio 0%

Performance

Latest +2.94%

1 Month -16.67%

3 Months -33.96%

6 Months -57.83%

1 Year -78.79%

3 Years -98.72%

5 Years -99.24%

10 Years -99.99%

Benchmarks

Market Capitalization

366 / 368

Gross Profits

0 / 278

Total Revenue

255 / 300

Total Rank

24 / 368

Free Cashflow

111 / 352

Performance 5 years

360 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.